CJ-12420

DRUG2 trials

Sponsors

HK inno.N Corporation

Conditions

Erosive EsophagitisGERDHealthy

Phase 1

Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects

CompletedNCT01473173

HK inno.N CorporationHealthy

Start: 2011-11-30End: 2012-08-31Updated: 2013-04-10

Phase 2

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

CompletedNCT02028663

HK inno.N CorporationErosive Esophagitis, GERD

Start: 2013-05-31End: 2014-05-31Updated: 2014-08-08